Jury Lets Merck Off Hook In Fosamax Bellwether Suit

Law360, New York (October 3, 2011, 3:29 PM EDT) -- A New York federal jury on Monday sided with Merck & Co. Inc. in a bellwether case in multidistrict litigation alleging Fosamax causes jaw deterioration — the fourth jury to do so in litigation over the osteoporosis drug.

It was the third time the drug company won a bellwether case in the MDL over the osteoporosis drug, and the fourth case in which a jury found for Merck. The verdict came after a judge dismissed every claim but one in the Florida plaintiff's suit.

“We believe...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Secrest v. Merck and Co., Inc.


Case Number

1:06-cv-06292

Court

New York Southern

Nature of Suit

Personal Inj. Prod. Liability

Judge

John F. Keenan

Date Filed

August 18, 2006


Case Title

In Re: Fosamax Products Liability Litigation


Case Number

1:06-md-01789

Court

New York Southern

Nature of Suit

Judge

John F. Keenan

Date Filed

August 18, 2006

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.